Medical Necessity of VenaSeal for Varicose Veins of Bilateral Lower Extremities

Patient Assessment and Criteria Met

The patient presents with bilateral leg pain, swelling, cramping, and bulging varicose veins that significantly interfere with activities of daily living, which are clear indications for intervention beyond conservative management 1, 2
Venous ultrasound demonstrates significant bilateral proximal and distal GSV reflux with enlarged veins, meeting the minimum diameter requirement of 2.5mm for treatment 3
The patient has tried conservative management with compression stockings for over 3 months with inadequate symptom relief, which is a prerequisite for procedural intervention 3
The patient has stasis dermatitis (CEAP C4), which represents moderate-to-severe venous disease requiring intervention to prevent progression 4, 3

The American College of Radiology recommends confirming diagnosis with duplex ultrasound, which has already been performed, showing bilateral GSV reflux 1, 5
The American College of Radiology suggests assessing severity of disease, and the patient has CEAP C4 disease with stasis dermatitis, indicating moderate-to-severe venous disease 4, 3
The guideline recommends verifying failure of conservative management, and the patient has worn compression stockings for over 3 months with inadequate relief 3
The American College of Radiology recommends selecting appropriate intervention, and for saphenous vein reflux, endovenous ablation techniques including VenaSeal are recommended as first-line treatments 3

Duplex ultrasound confirmation is mandatory before any interventional therapy and should document reflux duration ≥500 milliseconds at saphenofemoral junction, GSV diameter ≥2.5mm for VenaSeal, and assessment of deep venous system patency, as recommended by the American College of Radiology 6

The American College of Radiology recommends endovenous ablation as first-line treatment for symptomatic varicose veins with documented reflux, with a technical success rate of 96.5-100% and comparable long-term outcomes to radiofrequency ablation 6

Patients can anticipate significant symptom improvement, with a decrease in Venous Clinical Severity Score (VCSS) from baseline mean of 7.98 to 0.79 at 12 months with cyanoacrylate treatment, and a 100% healing rate for venous ulcers when present 6

VenaSeal has a "guarded safety profile" if not performed meticulously, with common side effects including transient superficial phlebitis in 18% of legs, and a rare but serious complication of deep venous extension of cyanoacrylate in 2.6% of cases 6